A study of ENT-01 in Parkinson’s disease with constipation.

About the KARMET study

KARMET is a Phase 2b clinical research study evaluating an investigational medication, ENT-01, for Parkinson’s disease with constipation. The purpose of the study is to evaluate the safety and efficacy of ENT-01 in treating constipation associated with Parkinson’s disease.

The study will be conducted at sites across the Unites States and will last up to 4 months in duration.

*Enrollment has closed for this study, thank you for your interest.